Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.

Malaria remains endemic at low levels in the south-eastern provinces of Iran bordering Afghanistan and Pakistan, with the majority of cases attributable to P. vivax. The national guidelines recommend chloroquine (CQ) as blood-stage treatment for uncomplicated P. vivax, but the large influx of import...

Full description

Bibliographic Details
Main Authors: Yaghoob Hamedi, Khojasteh Sharifi-Sarasiabi, Farzaneh Dehghan, Reza Safari, Sheren To, Irene Handayuni, Hidayat Trimarsanto, Ric N Price, Sarah Auburn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5102416?pdf=render
id doaj-66ac986809094968bbcdcca6881f56d9
record_format Article
spelling doaj-66ac986809094968bbcdcca6881f56d92020-11-25T01:46:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011111e016612410.1371/journal.pone.0166124Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.Yaghoob HamediKhojasteh Sharifi-SarasiabiFarzaneh DehghanReza SafariSheren ToIrene HandayuniHidayat TrimarsantoRic N PriceSarah AuburnMalaria remains endemic at low levels in the south-eastern provinces of Iran bordering Afghanistan and Pakistan, with the majority of cases attributable to P. vivax. The national guidelines recommend chloroquine (CQ) as blood-stage treatment for uncomplicated P. vivax, but the large influx of imported cases enhances the risk of introducing CQ resistance (CQR).The genetic diversity at pvmdr1, a putative modulator of CQR, and across nine putatively neutral short tandem repeat (STR) markers were assessed in P. vivax clinical isolates collected between April 2007 and January 2013 in Hormozgan Province, south-eastern Iran. One hundred blood samples were collected from patients with microscopy-confirmed P. vivax enrolled at one of five district clinics. In total 73 (73%) were autochthonous cases, 23 (23%) imported cases from Afghanistan or Pakistan, and 4 (4%) with unknown origin. 97% (97/100) isolates carried the F1076L mutation, but none carried the Y976F mutation. STR genotyping was successful in 71 (71%) isolates, including 57(57%) autochthonous and 11 (11%) imported cases. Analysis of population structure revealed 2 major sub-populations, K1 and K2, with further sub-structure within K2. The K1 sub-population had markedly lower diversity than K2 (HE = 0.06 vs HE = 0.82) suggesting that the sub-populations were sustained by distinct reservoirs with differing transmission dynamics, possibly reflecting local versus imported/introduced populations. No notable separation was observed between the local and imported cases although the sample size was limited.The contrasting low versus high diversity in the two sub-populations (K1 and K2) infers that a combination of local transmission and cross-border malaria from higher transmission regions shape the genetic make-up of the P. vivax population in south-eastern Iran. There was no molecular evidence of CQR amongst the local or imported cases, but ongoing clinical surveillance is warranted.http://europepmc.org/articles/PMC5102416?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Yaghoob Hamedi
Khojasteh Sharifi-Sarasiabi
Farzaneh Dehghan
Reza Safari
Sheren To
Irene Handayuni
Hidayat Trimarsanto
Ric N Price
Sarah Auburn
spellingShingle Yaghoob Hamedi
Khojasteh Sharifi-Sarasiabi
Farzaneh Dehghan
Reza Safari
Sheren To
Irene Handayuni
Hidayat Trimarsanto
Ric N Price
Sarah Auburn
Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
PLoS ONE
author_facet Yaghoob Hamedi
Khojasteh Sharifi-Sarasiabi
Farzaneh Dehghan
Reza Safari
Sheren To
Irene Handayuni
Hidayat Trimarsanto
Ric N Price
Sarah Auburn
author_sort Yaghoob Hamedi
title Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
title_short Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
title_full Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
title_fullStr Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
title_full_unstemmed Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.
title_sort molecular epidemiology of p. vivax in iran: high diversity and complex sub-structure using neutral markers, but no evidence of y976f mutation at pvmdr1.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Malaria remains endemic at low levels in the south-eastern provinces of Iran bordering Afghanistan and Pakistan, with the majority of cases attributable to P. vivax. The national guidelines recommend chloroquine (CQ) as blood-stage treatment for uncomplicated P. vivax, but the large influx of imported cases enhances the risk of introducing CQ resistance (CQR).The genetic diversity at pvmdr1, a putative modulator of CQR, and across nine putatively neutral short tandem repeat (STR) markers were assessed in P. vivax clinical isolates collected between April 2007 and January 2013 in Hormozgan Province, south-eastern Iran. One hundred blood samples were collected from patients with microscopy-confirmed P. vivax enrolled at one of five district clinics. In total 73 (73%) were autochthonous cases, 23 (23%) imported cases from Afghanistan or Pakistan, and 4 (4%) with unknown origin. 97% (97/100) isolates carried the F1076L mutation, but none carried the Y976F mutation. STR genotyping was successful in 71 (71%) isolates, including 57(57%) autochthonous and 11 (11%) imported cases. Analysis of population structure revealed 2 major sub-populations, K1 and K2, with further sub-structure within K2. The K1 sub-population had markedly lower diversity than K2 (HE = 0.06 vs HE = 0.82) suggesting that the sub-populations were sustained by distinct reservoirs with differing transmission dynamics, possibly reflecting local versus imported/introduced populations. No notable separation was observed between the local and imported cases although the sample size was limited.The contrasting low versus high diversity in the two sub-populations (K1 and K2) infers that a combination of local transmission and cross-border malaria from higher transmission regions shape the genetic make-up of the P. vivax population in south-eastern Iran. There was no molecular evidence of CQR amongst the local or imported cases, but ongoing clinical surveillance is warranted.
url http://europepmc.org/articles/PMC5102416?pdf=render
work_keys_str_mv AT yaghoobhamedi molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT khojastehsharifisarasiabi molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT farzanehdehghan molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT rezasafari molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT sherento molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT irenehandayuni molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT hidayattrimarsanto molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT ricnprice molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
AT sarahauburn molecularepidemiologyofpvivaxiniranhighdiversityandcomplexsubstructureusingneutralmarkersbutnoevidenceofy976fmutationatpvmdr1
_version_ 1725020954201948160